117 related articles for article (PubMed ID: 16008658)
21. Local reactions after subcutaneous injections of beta-interferon.
van Rengen A; Goossens A
Contact Dermatitis; 1998 Oct; 39(4):209. PubMed ID: 9817241
[No Abstract] [Full Text] [Related]
22. Erythema elevatum et diutinum, multiple sclerosis and interferon beta.
Gil M; Chizzolini C; Kaya G; Hauser C
Dermatology; 2004; 209(1):75-6. PubMed ID: 15237277
[No Abstract] [Full Text] [Related]
23. Treatment of heparin-induced thrombocytopenia.
Peters FP
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):517-8. PubMed ID: 9305220
[No Abstract] [Full Text] [Related]
24. Cutaneous mucinosis and skin necrosis complicates interferon alfacon-1 (consensus interferon) treatment of chronic hepatitis C.
Siewert E; Weyers W; Dietrich CG; Geier A; Lammert F; Matern S
Eur J Med Res; 2005 Feb; 10(2):63-7. PubMed ID: 15817424
[TBL] [Abstract][Full Text] [Related]
25. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
[No Abstract] [Full Text] [Related]
26. [Activation of psoriasis in patients undergoing treatment with interferon-beta].
Navne JE; Hedegaard U; Bygum A
Ugeskr Laeger; 2005 Aug; 167(32):2903-4. PubMed ID: 16109199
[TBL] [Abstract][Full Text] [Related]
27. C1-inhibitor activity and plasma concentrations in patients with monoclonal gammopathies: implications for treatment with recombinant interferon-beta 1b.
Schmidt S; Schneider T; Schmidt-Wolf I; Ko Y; Schlegel U; Klockgether T; Hertfelder HJ
Mult Scler; 2004 Apr; 10(2):243-4. PubMed ID: 15124772
[No Abstract] [Full Text] [Related]
28. Education and self-management of interferon beta-1b therapy for multiple sclerosis.
Keating MM; Ostby PL
J Neurosci Nurs; 1996 Dec; 28(6):350-2, 357-8. PubMed ID: 9007762
[TBL] [Abstract][Full Text] [Related]
29. [Interferon therapy of multiple sclerosis].
Jensen D
Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
[TBL] [Abstract][Full Text] [Related]
30. Does high-dose interferon beta-1b improve clinical response in more severely disabled multiple sclerosis patients?
Durelli L; Oggero A; Verdun E; Isoardo G; Ricci A; Barbero P; Bergamasco B
J Neurol Sci; 2000 Sep; 178(1):37-41. PubMed ID: 11018247
[TBL] [Abstract][Full Text] [Related]
31. Embolia cutis medicamentosa following interferon beta injection.
Koontz D; Alshekhlee A
Mult Scler; 2007 Nov; 13(9):1203-4. PubMed ID: 17967846
[No Abstract] [Full Text] [Related]
32. Acute acneiform eruption induced by interferon beta-1b during treatment for multiple sclerosis.
Rosa DJ; Matias Fde A; Cedrim SD; Machado RF; Sá AA; Silva VC
An Bras Dermatol; 2011; 86(2):336-8. PubMed ID: 21603818
[TBL] [Abstract][Full Text] [Related]
33. Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.
Kumasaka R; Nakamura N; Shirato K; Fujita T; Murakami R; Shimada M; Nakamura M; Osawa H; Yamabe H; Okumura K
Clin Exp Nephrol; 2006 Sep; 10(3):222-5. PubMed ID: 17009081
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous ulcerations following subcutaneous interferon beta injection to a patient with multiple sclerosis.
Inafuku H; Kasem Khan MA; Nagata T; Nonaka S
J Dermatol; 2004 Aug; 31(8):671-7. PubMed ID: 15492442
[TBL] [Abstract][Full Text] [Related]
35. Arthritis during interferon beta-1b treatment in multiple sclerosis.
Altintas A; Alici Y; Melikoğlu M; Siva A
Mult Scler; 2002 Dec; 8(6):534-6. PubMed ID: 12474998
[TBL] [Abstract][Full Text] [Related]
36. Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
Grossberg SE; Oger J; Grossberg LD; Gehchan A; Klein JP
J Interferon Cytokine Res; 2011 Mar; 31(3):337-44. PubMed ID: 21226608
[TBL] [Abstract][Full Text] [Related]
37. Local pain during REBIF injection is not due to acidic pH.
Buttmann M; Goebeler M; Rieckmann P
J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1078. PubMed ID: 15201384
[No Abstract] [Full Text] [Related]
38. [Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta].
Demina TL; Khachanova NV; Davydovskaia MV; Popova NF; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):24-6. PubMed ID: 18567192
[No Abstract] [Full Text] [Related]
39. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
[No Abstract] [Full Text] [Related]
40. Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report.
Broughton A; Cosyns JP; Jadoul M
Clin Nephrol; 2011 Nov; 76(5):396-400. PubMed ID: 22000560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
